DŁUG Zmiana Data
AbbVie USD 70.82B 2.04B 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amgen USD 57.3B 19M 2026-06
Arrowhead Research USD 983.69M 5.77M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Cytokinetics USD 1.27B 18.17M 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
J&J USD 49.04B 5.95B 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 35.09M 1.42M 2026-06
Merck USD 53.91B 4.79B 2026-06
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 62.67B 523M 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Xencor USD 170.11M 5.06M 2026-06